ArticleFrontiers in medicine2026
Benchmark evaluation of multi-modal large language models for ophthalmic diagnosis in real world.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multimodal large language models (MLLMs) are increasingly demonstrating substantial potential in the medical domain, particularly in image-intensive specialties such as ophthalmology. Although cutting-edge models like ChatGPT-4o and Qwen-VL 2.5 have shown strong performance on general-domain tasks, real-world clinical benchmarks for rigorously assessing their diagnostic capabilities in specialized medical contexts remain limited. To address this gap, we constructed a carefully curated benchmark dataset comprising 295 pathologically confirmed ophthalmic cases with representative clinical presentations. Using this dataset, we systematically evaluated nine leading MLLMs, including both open-source and proprietary models. The results showed that models such as HAIBU-ReMUD and ChatGPT-4o achieved comparatively strong diagnostic accuracy and consistency, with performance in some settings approaching that of human experts. These findings suggest that current MLLMs are showing encouraging feasibility for real-world clinical applications and provide a basis for further investigation of their integration into ophthalmology practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.